140 related articles for article (PubMed ID: 38579916)
1. Intranasal oxytocin as a treatment for anxiety and autism: From subclinical to clinical applications.
Yin H; Jiang M; Han T; Xu X
Peptides; 2024 Jun; 176():171211. PubMed ID: 38579916
[TBL] [Abstract][Full Text] [Related]
2. Long-term exposure to intranasal oxytocin in a mouse autism model.
Bales KL; Solomon M; Jacob S; Crawley JN; Silverman JL; Larke RH; Sahagun E; Puhger KR; Pride MC; Mendoza SP
Transl Psychiatry; 2014 Nov; 4(11):e480. PubMed ID: 25386957
[TBL] [Abstract][Full Text] [Related]
3. The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies.
Modi ME; Young LJ
Horm Behav; 2012 Mar; 61(3):340-50. PubMed ID: 22206823
[TBL] [Abstract][Full Text] [Related]
4. Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial.
Moerkerke M; Daniels N; Van der Donck S; Tibermont L; Tang T; Debbaut E; Bamps A; Prinsen J; Steyaert J; Alaerts K; Boets B
J Child Psychol Psychiatry; 2023 Nov; 64(11):1583-1595. PubMed ID: 37278339
[TBL] [Abstract][Full Text] [Related]
5. Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome.
Hall SS; Lightbody AA; McCarthy BE; Parker KJ; Reiss AL
Psychoneuroendocrinology; 2012 Apr; 37(4):509-18. PubMed ID: 21862226
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effects of oxytocin in autism: Current status of the research].
Gauthier C; Doyen C; Amado I; Lôo H; Gaillard R
Encephale; 2016 Feb; 42(1):24-31. PubMed ID: 26797566
[TBL] [Abstract][Full Text] [Related]
7. Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.
Alaerts K; Steyaert J; Vanaudenaerde B; Wenderoth N; Bernaerts S
Eur Neuropsychopharmacol; 2021 Feb; 43():147-152. PubMed ID: 33309460
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin ameliorates impaired social behavior in a Chd8 haploinsufficiency mouse model of autism.
Cherepanov SM; Gerasimenko M; Yuhi T; Furuhara K; Tsuji C; Yokoyama S; Nakayama KI; Nishiyama M; Higashida H
BMC Neurosci; 2021 May; 22(1):32. PubMed ID: 33933000
[TBL] [Abstract][Full Text] [Related]
9. The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder.
Greene RK; Spanos M; Alderman C; Walsh E; Bizzell J; Mosner MG; Kinard JL; Stuber GD; Chandrasekhar T; Politte LC; Sikich L; Dichter GS
J Neurodev Disord; 2018 Mar; 10(1):12. PubMed ID: 29587625
[TBL] [Abstract][Full Text] [Related]
10. Intranasal oxytocin in the treatment of anorexia nervosa: Randomized controlled trial during re-feeding.
Russell J; Maguire S; Hunt GE; Kesby A; Suraev A; Stuart J; Booth J; McGregor IS
Psychoneuroendocrinology; 2018 Jan; 87():83-92. PubMed ID: 29049935
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up.
Bernaerts S; Boets B; Bosmans G; Steyaert J; Alaerts K
Mol Autism; 2020; 11(1):6. PubMed ID: 31969977
[TBL] [Abstract][Full Text] [Related]
12. A common oxytocin receptor gene (OXTR) polymorphism modulates intranasal oxytocin effects on the neural response to social cooperation in humans.
Feng C; Lori A; Waldman ID; Binder EB; Haroon E; Rilling JK
Genes Brain Behav; 2015 Sep; 14(7):516-25. PubMed ID: 26178189
[TBL] [Abstract][Full Text] [Related]
13. Intranasal oxytocin effects on social cognition: a critique.
Evans SL; Dal Monte O; Noble P; Averbeck BB
Brain Res; 2014 Sep; 1580():69-77. PubMed ID: 24239931
[TBL] [Abstract][Full Text] [Related]
14. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
[TBL] [Abstract][Full Text] [Related]
15. An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism.
Meziane H; Schaller F; Bauer S; Villard C; Matarazzo V; Riet F; Guillon G; Lafitte D; Desarmenien MG; Tauber M; Muscatelli F
Biol Psychiatry; 2015 Jul; 78(2):85-94. PubMed ID: 25599930
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up.
Bernaerts S; Boets B; Steyaert J; Wenderoth N; Alaerts K
Transl Psychiatry; 2020 Nov; 10(1):383. PubMed ID: 33159033
[TBL] [Abstract][Full Text] [Related]
17. Plasma and CSF oxytocin levels after intranasal and intravenous oxytocin in awake macaques.
Freeman SM; Samineni S; Allen PC; Stockinger D; Bales KL; Hwa GG; Roberts JA
Psychoneuroendocrinology; 2016 Apr; 66():185-94. PubMed ID: 26826355
[TBL] [Abstract][Full Text] [Related]
18. Is the efficacy of oxytocin for autism diminished at higher dosages or repeated doses?: Potential mechanisms and candidate solutions.
Yamasue H
Peptides; 2024 Jan; 171():171133. PubMed ID: 38072084
[TBL] [Abstract][Full Text] [Related]
19. The impact of oxytocin administration on brain activity: a systematic review and meta-analysis protocol.
Quintana DS; Outhred T; Westlye LT; Malhi GS; Andreassen OA
Syst Rev; 2016 Nov; 5(1):205. PubMed ID: 27899138
[TBL] [Abstract][Full Text] [Related]
20. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
Guastella AJ; Einfeld SL; Gray KM; Rinehart NJ; Tonge BJ; Lambert TJ; Hickie IB
Biol Psychiatry; 2010 Apr; 67(7):692-4. PubMed ID: 19897177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
